AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Oramed Pharmaceuticals Inc. Proxy Solicitation & Information Statement 2024

Jun 20, 2024

6965_rns_2024-06-20_5c0f8547-edf6-4dad-9c77-654e70585775.htm

Proxy Solicitation & Information Statement

Opens in your device viewer

_________ false


��	2 381
ORAMED PHARMACEUTICALS INC
Corporation no: 980376008	12537
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	20/06/2024
	www.isa.gov.il			www.tase.co.il				Reference:	2024-02-062781	Time of broadcast: 14:43 14:43

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.


Attached hereto is a report on	Proxy Statement

DEF14_20240620_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 18/06/2024
Address: Avenue of the Americas 01185 , New York 10036 New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: [email protected] Company site: www.oramed.com

Previous names of reporting entity:

Name of the Signatory: GABAY AVRAHAM Position of Signatory in the reporting corporation: CFO & Secretary Name of Employer Company:
Address: Mamilla 20 , Jerusalem 9414904 Telephone: 052-5779725 Facsimile: 02-5660004 E-mail: [email protected] 1
USA